Kristina Carlson

The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations

Abou Dalle, Iman; Galimard, Jacques-Emmanuel; Poire, Xavier; Sanz, Jaime et al.

Part of Bone Marrow Transplantation, p. 326-332, 2026

• DOI for The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations

Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT

Vydra, Jan; Ferhat, Allain-Thibeault; Kröger, Nicolaus; Gedde-Dahl, Tobias et al.

Part of Bone Marrow Transplantation, p. 206-210, 2026

• DOI for Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT
• Download full text (pdf) of Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT

Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study

Silfverberg, Thomas; Cherif, Honar; Smitt, Emma; Carlson, Kristina

Part of eJHaem, 2026

• DOI for Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study
• Download full text (pdf) of Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study

Risk of infections in multiple myeloma: A populationbased study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry

Hveding Blimark, Cecilie; Carlson, Kristina; Day, Christopher; Einarsdottir, Sigrun et al.

Part of Haematologica, p. 163-172, 2025

• DOI for Risk of infections in multiple myeloma: A populationbased study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry
• Download full text (pdf) of Risk of infections in multiple myeloma: A populationbased study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry

BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party

Greco, Raffaella; Saccardi, Riccardo; Ponzano, Marta; Badoglio, Manuela et al.

Part of Bone Marrow Transplantation, p. 1628-1634, 2025

• DOI for BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party
• Download full text (pdf) of BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party

The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations

Abou Dalle, Iman; Galimard, Jacques-Emmanuel; Poire, Xavier; Sanz, Jaime et al.

Part of Bone Marrow Transplantation, p. 326-332, 2026

• DOI for The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations

Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT

Vydra, Jan; Ferhat, Allain-Thibeault; Kröger, Nicolaus; Gedde-Dahl, Tobias et al.

Part of Bone Marrow Transplantation, p. 206-210, 2026

• DOI for Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT
• Download full text (pdf) of Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT

Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study

Silfverberg, Thomas; Cherif, Honar; Smitt, Emma; Carlson, Kristina

Part of eJHaem, 2026

• DOI for Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study
• Download full text (pdf) of Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study

Risk of infections in multiple myeloma: A populationbased study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry

Hveding Blimark, Cecilie; Carlson, Kristina; Day, Christopher; Einarsdottir, Sigrun et al.

Part of Haematologica, p. 163-172, 2025

• DOI for Risk of infections in multiple myeloma: A populationbased study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry
• Download full text (pdf) of Risk of infections in multiple myeloma: A populationbased study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry

BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party

Greco, Raffaella; Saccardi, Riccardo; Ponzano, Marta; Badoglio, Manuela et al.

Part of Bone Marrow Transplantation, p. 1628-1634, 2025

• DOI for BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party
• Download full text (pdf) of BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party

Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis

Noui, Yassine; Zjukovskaja, Christina; Silfverberg, Thomas; Ljungman, Per et al.

Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 966-974, 2025

• DOI for Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis
• Download full text (pdf) of Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis

Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis

Hernandez-Boluda, Juan Carlos; Mosquera-Orgueira, Adrian; Gras, Luuk; Koster, Linda et al.

Part of Blood, p. 3139-3152, 2025

• DOI for Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis

Tuberculosis after hematopoietic cell transplantation: retrospective study on behalf of the infectious diseases working party of the EBMT

Drozd-Sokolowska, Joanna; Tridello, Gloria; Verheggen, Inge; Karakukcu, Musa et al.

Part of Bone Marrow Transplantation, p. 603-616, 2025

• DOI for Tuberculosis after hematopoietic cell transplantation: retrospective study on behalf of the infectious diseases working party of the EBMT

Income and education affect prognosis and treatment in symptomatic myeloma

Larfors, Gunnar; Carlson, Kristina; Day, Christopher; Einarsdottir, Sigrun et al.

Part of Annals of Hematology, p. 565-572, 2025

• DOI for Income and education affect prognosis and treatment in symptomatic myeloma
• Download full text (pdf) of Income and education affect prognosis and treatment in symptomatic myeloma

Patient-reported outcomes of quality of life before and after autologous hematopoietic stem cell transplantation for multiple sclerosis

Mitrache Desaga, Ann-Christine; Noui, Yassine; Silfverberg, Thomas; Carlson, Kristina et al.

Part of Multiple Sclerosis Journal, p. 455-463, 2025

• DOI for Patient-reported outcomes of quality of life before and after autologous hematopoietic stem cell transplantation for multiple sclerosis
• Download full text (pdf) of Patient-reported outcomes of quality of life before and after autologous hematopoietic stem cell transplantation for multiple sclerosis

Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group

Partanen, Anu; Waage, Anders; Peceliunas, Valdas; Schjesvold, Fredrik et al.

Part of Cancers, p. 1024-1024, 2024

• DOI for Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group
• Download full text (pdf) of Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group

Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study

Moser, Olga; Ngoya, Maud; Galimard, Jacques-Emmanuel; Dalissier, Arnaud et al.

Part of Bone Marrow Transplantation, p. 604-614, 2024

• DOI for Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study
• Download full text (pdf) of Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study

Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Silfverberg, Thomas; Zjukovskaja, Christina; Ljungman, Per; Nahimi, Adjmal et al.

Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 125-133, 2024

• DOI for Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
• Download full text (pdf) of Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis

Silfverberg, Thomas; Zjukovskaja, Christina; Noui, Yassine; Carlson, Kristina et al.

Part of Bone Marrow Transplantation, p. 1601-1610, 2024

• DOI for BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis
• Download full text (pdf) of BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis

Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies

Arrieta-Bolaños, Esteban; Bonneville, Edouard F.; Crivello, Pietro; Robin, Marie et al.

Part of Journal of Clinical Oncology, p. 3287-3299, 2024

• DOI for Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies

Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation

De Greef, Julien; Averbuch, Dina; Tondeur, Laura; Duréault, Amélie et al.

Part of Journal of Infection, 2024

• DOI for Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
• Download full text (pdf) of Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation

Graft-versus-Host Disease Prophylaxis with PostTransplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)

Ortí, Guillermo; Gras, Luuk; Koster, Linda; Kulagin, Aleksander et al.

Part of Transplantation and Cellular Therapy, p. 930-93000000000000, 2024

• DOI for Graft-versus-Host Disease Prophylaxis with PostTransplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)

Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19: An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry

Ljungman, Per; Tridello, Gloria; Pinana, Jose Luis; Ciceri, Fabio et al.

Part of Frontiers in Immunology, 2023

• DOI for Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19: An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry
• Download full text (pdf) of Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19: An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry

Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis

Zafeiri, Lida; Åkerfeldt, Torbjörn; Tolf, Andreas; Carlson, Kristina et al.

Part of PLOS ONE, 2023

• DOI for Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis
• Download full text (pdf) of Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis

Impact of daratumumab-based induction on stem cell collection parameters in Swedish myeloma patients

Lemonakis, Konstantinos; Tätting, Love; Lisak, Mikael; Carlson, Kristina et al.

Part of Haematologica, p. 610-614, 2023

• DOI for Impact of daratumumab-based induction on stem cell collection parameters in Swedish myeloma patients
• Download full text (pdf) of Impact of daratumumab-based induction on stem cell collection parameters in Swedish myeloma patients

Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT

Bug, Gesine; Labopin, Myriam; Niittyvuopio, Riitta; Stelljes, Matthias et al.

Part of Bone Marrow Transplantation, p. 710-716, 2023

• DOI for Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
• Download full text (pdf) of Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT

Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study

Silfverberg, Thomas; Wahlin, Bjorn; Carlson, Kristina; Cherif, Honar

Part of Upsala Journal of Medical Sciences, 2022

• DOI for Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study
• Download full text (pdf) of Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study

Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group

Gregersen, Henrik; Peceliunas, Valdas; Remes, Kari; Schjesvold, Fredrik et al.

Part of European Journal of Haematology, p. 34-44, 2022

• DOI for Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group
• Download full text (pdf) of Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group

Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT

Machowicz, Rafal; Suarez, Felipe; Wiktor-Jedrzejczak, Wieslaw; Eikema, Diderik-Jan et al.

Part of Bone Marrow Transplantation, p. 817-823, 2022

• DOI for Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT

Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study

Zhukovsky, Christina; Sandgren, Sofia; Silfverberg, Thomas; Einarsdottir, Sigrun et al.

Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 189-194, 2021

• DOI for Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study
• Download full text (pdf) of Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study

Quantification of (11)C-PIB kinetics in cardiac amyloidosis

Kero, Tanja; Sörensen, Jens; Antoni, Gunnar; Wilking, Helena et al.

Part of Journal of Nuclear Cardiology, p. 774-784, 2020

• DOI for Quantification of (11)C-PIB kinetics in cardiac amyloidosis
• Download full text (pdf) of Quantification of (11)C-PIB kinetics in cardiac amyloidosis

Diagnostic Accuracy of [¹¹C]PIB Positron Emission Tomography for Detection of Cardiac Amyloidosis

Rosengren, Sara; Skibsted Clemmensen, Tor; Tolbod, Lars; Granstam, Sven-Olof et al.

Part of JACC Cardiovascular Imaging, p. 1337-1347, 2020

• DOI for Diagnostic Accuracy of [¹¹C]PIB Positron Emission Tomography for Detection of Cardiac Amyloidosis

Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis

Larsson, Diane; Åkerfeldt, Torbjörn; Carlson, Kristina; Burman, Joachim

Part of Multiple Sclerosis Journal, p. 1351-1359, 2020

• DOI for Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis

Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry

Wålinder, Göran; Samuelsson, Jan; Näsman, Per; Hansson, Markus et al.

Part of European Journal of Haematology, p. 376-382, 2020

• DOI for Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry

Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation

Tolf, Andreas; Fagius, Jan; Carlson, Kristina; Åkerfeldt, Torbjörn et al.

Part of Acta Neurologica Scandinavica, p. 320-327, 2019

• DOI for Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation

High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort Study

Vaht, Krista; Goransson, Magnus; Carlson, Kristina; Isaksson, Cecilia et al.

Part of Biology of blood and marrow transplantation, p. 1970-1974, 2019

• DOI for High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort Study

Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation

Raj, Kavita; Eikema, Diderik-Jan; McLornanl, Donal P.; Olavarria, Eduardo et al.

Part of Biology of blood and marrow transplantation, p. 522-528, 2019

• DOI for Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation

Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial

Burt, Richard K.; Balabanov, Roumen; Burman, Joachim; Sharrack, Basil et al.

Part of Journal of the American Medical Association (JAMA), p. 165-174, 2019

• DOI for Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial

Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT

McLornan, Donal P.; Szydlo, Richard; Robin, Marie; van Biezen, Anja et al.

Part of British Journal of Haematology, p. 418-422, 2018

• DOI for Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT

Health-related quality of life in multiple myeloma patients with first relapse treated with Carfilzomib-based re-induction and salvage autologous stem cell transplantation: data from a Nordic phase II trial

Eshoj, Henrik Rode; Nielsen, Lene Kongsgaard; Schjesvold, Fredrik; Abildgaard, Niels et al.

Part of Quality of Life Research, 2018

• DOI for Health-related quality of life in multiple myeloma patients with first relapse treated with Carfilzomib-based re-induction and salvage autologous stem cell transplantation: data from a Nordic phase II trial

Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia A Swedish nationwide cohort study

Vaht, Krista; Goransson, Magnus; Carlson, Kristina; Isaksson, Cecilia et al.

Part of European Journal of Haematology, p. 613-620, 2018

• DOI for Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia A Swedish nationwide cohort study

Outcome and survival of myeloma patients diagnosed 2008-2015. Real world data on 4904 patients from the Swedish Myeloma Registry (SMR)

Blimark, Cecilie Hveding; Turesson, Ingemar; Genell, Anna; Ahlberg, Lucia et al.

Part of Haematologica, p. 506-513, 2018

• DOI for Outcome and survival of myeloma patients diagnosed 2008-2015. Real world data on 4904 patients from the Swedish Myeloma Registry (SMR)

Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Burman, Joachim; Kirgizov, K; Carlson, Kristina; Badoglio, M et al.

Part of Bone Marrow Transplantation, p. 1133-1137, 2017

• DOI for Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Family mismatched allogeneic stem cell transplantationfor myelofibrosis: Report from the chronic malignancies working party of EBMT

Raj, K.; Olavarria, E.; Eikema, D-J; Blok, H-J et al.

Part of Bone Marrow Transplantation, 2017

• DOI for Family mismatched allogeneic stem cell transplantationfor myelofibrosis: Report from the chronic malignancies working party of EBMT

Allogeneic Hematopoietic Stem Cell Transplantation Provides Cure for Adult Patients with Hemophagocytic Lymphohistiocytosis (HLH): A Retrospective Study of The Chronic Malignancies and Inborn ErrorsWorking Parties (CMWP and IEWP) of The EBMT

Machowcz, Rafal; Suarez, Felipe; Wiktor-Jedrzejczak, Wieslaw; Eikema, Diderik-Jan et al.

Part of Pediatric Blood & Cancer, 2017

Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011

Vaht, Krista; Goransson, Magnus; Carlson, Kristina; Isaksson, Cecilia et al.

Part of Haematologica, p. 1683-1690, 2017

• DOI for Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011
• Download full text (pdf) of Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011

Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register

Nahi, Hareth; Genell, Anna; Walinder, Goran; Uttervall, Katarina et al.

Part of European Journal of Haematology, p. 216-222, 2017

• DOI for Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register

Successful autologous haematopoietic stem cell transplantation for refractory myasthenia gravis - a case report

Håkansson, Irene; Sandstedt, Anna; Lundin, Fredrik; Askmark, Håkan et al.

Part of Neuromuscular Disorders, p. 90-93, 2017

• DOI for Successful autologous haematopoietic stem cell transplantation for refractory myasthenia gravis - a case report

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009.

Rosengren, Sara; Mellqvist, U-H; Nahi, H; Forsberg, K et al.

Part of Bone Marrow Transplantation, p. 1569-1572, 2016

• DOI for Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009.

Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party

Greco, Raffaella; Bondanza, Attilio; Oliveira, Maria Carolina; Badoglio, Manuela et al.

Part of Multiple Sclerosis Journal, p. 189-197, 2015

• DOI for Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party

Second allogeneic stem cell transplant for aplastic anaemia: a retrospective study by the severe aplastic anaemia working party of the European society for blood and marrow transplantation

Cesaro, Simone; de latour, Regis Peffault; Tridello, Gloria; Pillon, Marta et al.

Part of British Journal of Haematology, p. 606-614, 2015

• DOI for Second allogeneic stem cell transplant for aplastic anaemia: a retrospective study by the severe aplastic anaemia working party of the European society for blood and marrow transplantation

Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population

Liwing, Johan; Uttervall, Katarina; Lund, Johan; Aldrin, Anders et al.

Part of British Journal of Haematology, p. 684-693, 2014

• DOI for Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience

Burman, Joachim; Iacobaeus, Ellen; Svenningsson, Anders; Lycke, Jan et al.

Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 1116-1121, 2014

• DOI for Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience

Evaluation of patients with cardiac amyloidosis using echocardiography, ECG and right heart catheterization

Granstam, Sven-Olof; Rosengren, Sara; Vedin, Ola; Kero, Tanja et al.

Part of Amyloid, p. 27-33, 2013

• DOI for Evaluation of patients with cardiac amyloidosis using echocardiography, ECG and right heart catheterization

In Vivo Visualization of Amyloid Deposits in the Heart with ¹¹C-PIB and PET

Antoni, Gunnar; Lubberink, Mark; Estrada, Sergio; Axelsson, Jan et al.

Part of Journal of Nuclear Medicine, p. 213-220, 2013

• DOI for In Vivo Visualization of Amyloid Deposits in the Heart with ¹¹C-PIB and PET

Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial

Russell, Nigel; Douglas, Kenny; Ho, Anthony; Mohty, Mohamad et al.

Part of Haematologica, p. 172-178, 2013

• DOI for Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial

A Combination Regimen of Bortezomib, Cyclophosphamide and Betamethasone Gives Quicker, Better and More Durable Response than VAD/CyBet Regimens: Results from a Swedish Retrospective Analysis

Uttervall, Katarina; Admasie, Johannes; Alici, Evren; Lund, Johan et al.

Part of Acta Haematologica, p. 7-15, 2013

• DOI for A Combination Regimen of Bortezomib, Cyclophosphamide and Betamethasone Gives Quicker, Better and More Durable Response than VAD/CyBet Regimens: Results from a Swedish Retrospective Analysis

New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation

Daikeler, Thomas; Labopin, Myriam; Ruggeri, Annalisa; Crotta, Alessandro et al.

Part of Blood, p. 1059-1064, 2013

• DOI for New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation

Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT

Jantunen, Esa; Boumendil, Ariane; Finel, Herve; Luan, Jian-Jian et al.

Part of Blood, p. 2529-2532, 2013

• DOI for Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Mellqvist, Ulf-Henrik; Gimsing, Peter; Hjertner, Oyvind; Lenhoff, Stig et al.

Part of Blood, p. 4647-4654, 2013

• DOI for Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study

Hjorth, Martin; Hjertner, Oyvind; Knudsen, Lene Meldgaard; Gulbrandsen, Nina et al.

Part of European Journal of Haematology, p. 485-496, 2012

• DOI for Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study

Is Multiple Myeloma a Chronic Disease?: A Population Based Study Comparing 1843 Patients to a Matched Swedish Population

Nahi, Hareth; Liwing, Johan; Aldrin, Anders; Andreasson, Johan et al.

Part of Blood, p. 2970, 2012

Mandibular osteomyelitis associated with paroxysmal nocturnal hemoglobinuria

Kharazmi, M; Carlson, Kristina; Björnstad, L; Petersson, A et al.

Part of International Journal of Oral and Maxillofacial Surgery, p. 1441-1444, 2011

• DOI for Mandibular osteomyelitis associated with paroxysmal nocturnal hemoglobinuria

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

Waage, Anders; Gimsing, Peter; Fayers, Peter; Abildgaard, Niels et al.

Part of Blood, p. 1405-1412, 2010

• DOI for Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial

Gimsing, Peter; Carlson, Kristina; Turesson, Ingemar; Fayers, Peter et al.

Part of The Lancet Oncology, p. 973-982, 2010

• DOI for Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial

Population-based incidence, prevalence and survival of systemic AL amyloidosis in Sweden

Rosengren, Sara; Thelander, Ulrika; Mattsson, Mattias; Carlson, Kristina